Global Proton Therapy Market – Industry Trends - Forecast to 2026

  • Pharmaceutical
  • Upcoming Reports
  • Mar 2019
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220
Global Proton Therapy Market By Product (Equipment, Service), Type (Electron Beam, Proton Beam, Neutron Beam, Carbon Ion Beam, Alpha Particle Beam, Beta Particle Beam), Set-Up Systems (Single-Room Systems, Multi-Room Systems, Compact Systems), Indication (Pediatric Cancer, Pelvic Cancer, Sarcoma, Prostate Cancer, Lung Cancer, Bone & Soft Tissue Cancer, Gastro-Intestinal Cancer, Liver Cancer, Brain Tumor, Central Nervous System, Eye Cancer, Head & Neck Cancer, Others), End-User (Hospitals, Ambulatory Surgical Centers, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)– Industry Trends & Forecast to 2026

Market Analysis: Global Proton Therapy Market

Global Proton Therapy Market is expected to rise from its initial estimated value of USD 1.13 billion in 2018 to a projected value of USD 3.56 billion by 2026, registering a CAGR of 15.34% in the forecast period of 2019-2026. This rise in market value can be attributed to growth of the population suffering from cancer.

Market Definition: Global Proton Therapy Market

Proton therapy is a pharmaceutical technique which involves the treatment of cancerous cells and tumor, it involves the usage of radiation devices and focused radiation therapy along with accelerated protons which act as the radiation source. Through proton therapy, physicians can completely focus the radiation therapy on only the cancerous cells rather than damaging the healthy tissues and organs in close quarters of the targeted area.

Market Drivers

  • Increasing investments and funding for advancements in technologies of treatment in cancer treatments as well as increasing the establishment of proton therapy centers; this factor is expected to act as a driver for the market growth
  • Innovations and advancements in the therapeutic systems of cancer treatments and advancements in proton therapy product offerings; this factor is expected to act as a driver for the market growth

Market Restraint

  • Requirement of large funds initially for establishing and usage of proton therapy is expected to restrain the market growth

Segmentation: Global Proton Therapy Market

  • By Product

    • Equipment
    • Service

  • By Type

    • Electron Beam
    • Proton Beam
    • Neutron Beam
    • Carbon Ion Beam
    • Alpha Particle Beam
    • Beta Particle Beam

  • By Set-Up Systems

    • Single-Room Systems
    • Multi-Room Systems
    • Compact Systems

  • By Indication

    • Pediatric Cancer
    • Pelvic Cancer
    • Sarcoma
    • Prostate Cancer
    • Lung Cancer
    • Bone & Soft Tissue Cancer
    • Gastro-Intestinal Cancer
    • Liver Cancer
    • Brain Tumor
    • Central Nervous System
    • Eye Cancer
    • Head & Neck Cancer
    • Others

      • Renal Cell Carcinoma
      • Cervical
      • Gastric
      • Lymphoma

  • By End-User

    • Hospitals
    • Ambulatory Surgical Centers
    • Others

  • By Geography

    • North America

      • US.
      • Canada
      • Mexico

    • South America

      • Brazil
      • Argentina
      • Rest of South America

    • Europe

      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
      • Russia
      • Turkey
      • Belgium
      • Netherlands
      • Switzerland
      • Rest of Europe

    • Asia-Pacific

      • Japan
      • China
      • South Korea
      • India
      • Australia
      • Singapore
      • Thailand
      • Malaysia
      • Indonesia
      • Philippines
      • Rest of Asia Pacific

    • Middle East & Africa

      • South Africa
      • Egypt
      • Saudi Arabia
      • United Arab Emirates
      • Israel
      • Rest of Middle East & Africa

Key Developments in the Market:

  • In January 2019, Apollo Hospitals Enterprise Ltd. announced the launch of South Asia’s first proton therapy situated in Tamil Nadu, India. The center equipped with pencil-beam scanning technology offering which offers the highest precision of therapy.
  • In September 2018, Hitachi, Ltd. announced that they had received an order from Tokushukai Medical Group for usage in Shonan Kamakura Advanced Medical Center for Hitachi’s compact proton therapy system. The dedicated system is expected to be completed by September 2020.
  • In January 2018, Hitachi, Ltd. announced that they had received US FDA 510(k) clearance for their commercialization of “Real Time Image Gating System for Proton Beam Therapy Systems”. This clearance will allow for patients in United States to be treated with cutting-edge motion management and enhanced Spot Scanning identification technology.

Competitive Analysis:

Global proton therapy market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of proton therapy market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Mevion Medical Systems; ProTom International; Hitachi, Ltd.; IBA Worldwide; Sumitomo Heavy Industries, Ltd.; Varian Medical Systems, Inc.; Koninklijke Philips N.V.; Mitsubishi Electric Corporation; Fermilab; Optivus Proton Therapy, Inc.; Elekta AB (pub); Advanced Oncotherapy; are few of the major competitors present in the market.

Research Methodology: Global Proton Therapy Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or can drop down your inquiry.

The key research methodology used by DBMR Research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global proton therapy market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

SKU-

Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

Please fill in the below form for detailed Inquire Before Buying

Choose License Type
  • $5400.00
  • $4200.00
BUY NOW ADD TO CART